Roche receives FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough (pertussis)

The point-of-care test delivers PCR-accurate results in just 15 minutes, enabling healthcare providers to act quickly and ...
Yahoo Finance

Roche launches cobas 5800, a new molecular diagnostics system to expand access to testing and improve patient care

Infectious diseases, such as those infections transmitted via respiratory, sexually and transplant, are becoming increasingly difficult to manage and represent an ever-growing medical need for ...
Nasdaq

Roche launches cobas prime Pre-analytical System, a first-of-its-kind solution designed to automate all common manual steps in molecular diagnostics laboratories

PLEASANTON, Calif., July 30, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® prime Pre-analytical System to improve efficiency in molecular diagnostics ...
Nasdaq

Roche launches cobas pure integrated solutions analyser to help simplify operations in small to medium sized labs

Basel, 17 March 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of cobas pure integrated solutions in countries accepting the CE mark.3 This new compact analyser combines three ...
News Medical

Roche launches cobas(R) 4800 System in Canada for testing CT, NG and HPV

New cobas(R) 4800 System designed to increase laboratory efficiency and medical value Roche Diagnostics Canada (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of a new Health Canada approved ...
Modern Healthcare

FDA warns of potential false positive results with Roche Cobas rapid coronavirus, flu test

The US Food and Drug Administration released a letter on Friday warning clinical laboratory and point-of-care staff, as well as healthcare providers, that false positive results for Roche's test for ...
Newswire

Roche launches the cobas® EGFR Mutation Test v2 for use with either plasma or tumor tissue samples

The next-generation test from Roche includes expanded mutation coverage of the epidermal growth factor receptor (EGFR) gene in DNA derived from tumor tissue and liquid biopsy. The test can be used to ...
PharmiWeb

Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care

Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care Handheld blood glucose ...
FierceBiotech

FDA approves Roche's first cobas test for whole blood donor screening

The FDA has approved Roche’s first commercial test for screening whole blood donations to detect a parasite transmitted by ticks that lives within red blood cells and can cause potentially fatal ...
Business Insider

Roche Launches Cobas SARS-CoV-2 Variant Set 1 Test To Detect SARS-CoV-2 Mutations

(RTTNews) - Roche (RHHBY) announced the launch of the cobas SARS-CoV-2 Variant Set 1 Test to detect and differentiate mutations found in variants that originated in the UK, South Africa, and Brazil.
PharmiWeb

Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care

Handheld blood glucose management device designed around the specific needs of healthcare professionals working in a range of care settings First diagnostic solution at the point of care to serve as a ...